학술논문

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study.
Document Type
Article
Source
Acta Dermato-Venereologica; 2023, Vol. 103, p1-3, 3p
Subject
DIMETHYL fumarate
PSORIASIS
Language
ISSN
00015555
Abstract
The article focuses on assessing the effectiveness and safety of a new oral formulation of dimethyl fumarate (DMF) in treating adults with moderate-to-severe chronic plaque psoriasis in a real-life setting. Topics include the study's retrospective analysis of DMF-treated patients, the evaluation of Psoriasis Area and Severity Index (PASI) reduction, and the observation of adverse events and treatment discontinuations.